These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 18586661
1. Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone. Mulder P, Mellin V, Favre J, Vercauteren M, Remy-Jouet I, Monteil C, Richard V, Renet S, Henry JP, Jeng AY, Webb RL, Thuillez C. Eur Heart J; 2008 Sep; 29(17):2171-9. PubMed ID: 18586661 [Abstract] [Full Text] [Related]
2. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?]. Brilla CG, Schencking M, Scheer C, Rupp H. Praxis (Bern 1994); 1997 Apr 02; 86(14):566-74. PubMed ID: 9198851 [Abstract] [Full Text] [Related]
3. Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure. Mellin V, Isabelle M, Oudot A, Vergely-Vandriesse C, Monteil C, Di Meglio B, Henry JP, Dautreaux B, Rochette L, Thuillez C, Mulder P. Eur Heart J; 2005 Aug 02; 26(15):1544-50. PubMed ID: 15872033 [Abstract] [Full Text] [Related]
7. Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia. Fang Y, Debunne M, Vercauteren M, Brakenhielm E, Richard V, Lallemand F, Henry JP, Mulder P, Thuillez C. J Cardiovasc Pharmacol; 2012 Mar 02; 59(3):260-7. PubMed ID: 22075752 [Abstract] [Full Text] [Related]
8. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C. Circulation; 2004 Apr 06; 109(13):1674-9. PubMed ID: 14981003 [Abstract] [Full Text] [Related]
9. Aldosterone antagonism improves endothelial-dependent vasorelaxation in heart failure via upregulation of endothelial nitric oxide synthase production. Thai HM, Do BQ, Tran TD, Gaballa MA, Goldman S. J Card Fail; 2006 Apr 06; 12(3):240-5. PubMed ID: 16624690 [Abstract] [Full Text] [Related]
10. Spironolactone improves carotid artery fibrosis and distensibility in rat post-ischaemic heart failure. Nehme JA, Lacolley P, Labat C, Challande P, Robidel E, Perret C, Leenhardt A, Safar ME, Delcayre C, Milliez P. J Mol Cell Cardiol; 2005 Sep 06; 39(3):511-9. PubMed ID: 15992819 [Abstract] [Full Text] [Related]
15. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats. Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T. Eur J Pharmacol; 2008 Jul 28; 589(1-3):264-71. PubMed ID: 18582458 [Abstract] [Full Text] [Related]
16. Chronic heart failure: an overview of conventional treatment versus novel approaches. Landmesser U, Drexler H. Nat Clin Pract Cardiovasc Med; 2005 Dec 28; 2(12):628-38. PubMed ID: 16306919 [Abstract] [Full Text] [Related]
17. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction. Fraccarollo D, Galuppo P, Hildemann S, Christ M, Ertl G, Bauersachs J. J Am Coll Cardiol; 2003 Nov 05; 42(9):1666-73. PubMed ID: 14607457 [Abstract] [Full Text] [Related]